One of the most immediate impacts of AI in medical genetics lies in diagnosis, particularly for rare and complex genetic ...
Myriad Genetics Q3 2025 slides: volume growth offsets revenue decline, CCC strategy advances ...
Myriad Genetics reported total revenue of $196 million for Q1 2025, down 3% from $202 million in the same period last year. The company posted an adjusted loss per share of $0.03, compared to a loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback